洛美沙星和替马沙星对引起腹泻病原体的体外活性
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.
作者信息
Segreti J, Nelson J A, Goodman L J, Kaplan R L, Trenholme G M
机构信息
Department of Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612.
出版信息
Antimicrob Agents Chemother. 1989 Aug;33(8):1385-7. doi: 10.1128/AAC.33.8.1385.
Abstract
The in vitro activities of temafloxacin (A63004) and lomefloxacin (SC-47111; NY-198) were compared with those of seven other antibiotics against 146 isolates of bacterial enteric pathogens, including Campylobacter jejuni and Campylobacter coli. Ciprofloxacin was the most active drug against the Salmonella, Shigella, Yersinia, and Vibrio spp. tested. Lomefloxacin, temafloxacin, and difloxacin were the most active drugs tested against Campylobacter spp. (MIC for 90% of strains, 0.125 to 0.25 micrograms/ml).
摘要
将替马沙星（A63004）和洛美沙星（SC-47111；NY-198）的体外活性与其他七种抗生素针对146株肠道病原菌（包括空肠弯曲菌和结肠弯曲菌）的活性进行了比较。环丙沙星是针对所测试的沙门氏菌、志贺氏菌、耶尔森氏菌和弧菌属最具活性的药物。洛美沙星、替马沙星和二氟沙星是针对弯曲菌属测试的最具活性的药物（90%菌株的MIC为0.125至0.25微克/毫升）。
相似文献
1
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.洛美沙星和替马沙星对引起腹泻病原体的体外活性
Antimicrob Agents Chemother. 1989 Aug;33(8):1385-7. doi: 10.1128/AAC.33.8.1385.
2
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.妥舒沙星、替马沙星和A-56620对腹泻病原体的体外活性
Antimicrob Agents Chemother. 1990 Feb;34(2):368-70. doi: 10.1128/AAC.34.2.368.
3
Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.二氟喹诺酮类药物洛美沙星的体外活性比较
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):65S-76S. doi: 10.1016/0732-8893(89)90069-2.
4
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.替马沙星、托氟沙星（A-61827）及其他五种氟喹诺酮类药物的体外活性
J Antimicrob Chemother. 1989 Apr;23(4):527-35. doi: 10.1093/jac/23.4.527.
5
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.十二种4-喹诺酮类抗菌药物对肠道病原体的体外活性比较
Drugs Exp Clin Res. 1985;11(4):253-7.
6
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.洛美沙星（SC - 47111；NY - 198），一种二氟喹诺酮3 - 羧酸，与其他喹诺酮类药物相比的体外活性。
Antimicrob Agents Chemother. 1988 May;32(5):656-62. doi: 10.1128/AAC.32.5.656.
7
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Diagn Microbiol Infect Dis. 1988 Aug;10(4):221-40. doi: 10.1016/0732-8893(88)90094-6.
8
Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.洛美沙星（SC 47111或NY - 198）对新鲜临床分离细菌的体外活性比较
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):7S-11S. doi: 10.1016/0732-8893(89)90058-8.
9
A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.在阿根廷进行的一项关于洛美沙星（NY - 198或SC 47111）抗菌活性的十实验室研究。
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):45S-50S. doi: 10.1016/0732-8893(89)90065-5.
10
Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.洛美沙星SC 47111（NY - 198）和环丙沙星对特定病原体的杀菌活性。
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):29S-34S. doi: 10.1016/0732-8893(89)90062-x.
引用本文的文献
1
In vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calves.头孢菌素和喹诺酮类药物对从腹泻乳牛犊分离出的大肠杆菌菌株的体外活性。
Antimicrob Agents Chemother. 1999 Mar;43(3):510-3. doi: 10.1128/AAC.43.3.510.
2
Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones.从痢疾患者中分离出的宋内志贺菌菌株对氟喹诺酮类药物的敏感性降低。
Antimicrob Agents Chemother. 1993 Nov;37(11):2486-9. doi: 10.1128/AAC.37.11.2486.
3
In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.依诺沙星、恩诺沙星、司帕沙星和环丙沙星对从腹泻羔羊和幼崽分离出的大肠杆菌菌株的体外活性。
Antimicrob Agents Chemother. 1994 Oct;38(10):2469-70. doi: 10.1128/AAC.38.10.2469.
4
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.妥舒沙星、替马沙星和A-56620对腹泻病原体的体外活性
Antimicrob Agents Chemother. 1990 Feb;34(2):368-70. doi: 10.1128/AAC.34.2.368.
5
Effect of lomefloxacin on the normal oral and intestinal microflora.洛美沙星对正常口腔及肠道微生物群落的影响。
Eur J Clin Microbiol Infect Dis. 1990 Jan;9(1):35-9. doi: 10.1007/BF01969531.
6
Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.洛美沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1991 Dec;42(6):1018-60. doi: 10.2165/00003495-199142060-00009.
7
Characterization of high-level quinolone resistance in Campylobacter jejuni.空肠弯曲菌中高水平喹诺酮耐药性的特征分析
Antimicrob Agents Chemother. 1991 May;35(5):840-5. doi: 10.1128/AAC.35.5.840.
8
Activities of newer fluoroquinolones against Shigella sonnei.新型氟喹诺酮类药物对宋内志贺菌的活性。
Antimicrob Agents Chemother. 1992 Oct;36(10):2346-8. doi: 10.1128/AAC.36.10.2346.
本文引用的文献
1
Hippurate hydrolysis by Campylobacter fetus.胎儿弯曲菌对马尿酸盐的水解作用。
J Clin Microbiol. 1980 Apr;11(4):435-7. doi: 10.1128/jcm.11.4.435-437.1980.
2
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.环丙沙星对弯曲杆菌属及其他肠道病原菌的体外活性比较
Antimicrob Agents Chemother. 1984 Apr;25(4):504-6. doi: 10.1128/AAC.25.4.504.
3
In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics.艰难梭菌对新型β-内酰胺类和喹诺酮类抗生素的体外敏感性
Antimicrob Agents Chemother. 1985 Dec;28(6):842-4. doi: 10.1128/AAC.28.6.842.
4
Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.十二种抗菌剂对弯曲杆菌属细菌的体外活性比较
Antimicrob Agents Chemother. 1985 Mar;27(3):429-30. doi: 10.1128/AAC.27.3.429.
5
Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.环丙沙星与安慰剂治疗细菌性腹泻的临床疗效比较。
Am J Med. 1987 Apr 27;82(4A):329-32.
6
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.环丙沙星或复方新诺明作为旅行者腹泻的初始治疗：一项安慰剂对照随机试验
Ann Intern Med. 1987 Feb;106(2):216-20. doi: 10.7326/0003-4819-106-2-216.
7
In vitro and in vivo activity of NY-198, a new difluorinated quinolone.新型二氟喹诺酮NY-198的体外和体内活性
Antimicrob Agents Chemother. 1987 Jun;31(6):854-9. doi: 10.1128/AAC.31.6.854.
8
Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.盐酸替马沙星（A-62254）与两种氟喹诺酮类对照品的抗菌活性比较
Antimicrob Agents Chemother. 1987 Nov;31(11):1768-74. doi: 10.1128/AAC.31.11.1768.
9
Antimicrobial therapy for enteric infections and typhoid fever: state of the art.肠道感染和伤寒的抗菌治疗：最新进展
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S199-205. doi: 10.1093/clinids/10.supplement_1.s199.
10
Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.洛美沙星口服剂量递增后的药代动力学及耐受性
Antimicrob Agents Chemother. 1988 Oct;32(10):1503-7. doi: 10.1128/AAC.32.10.1503.
Zotero 插件